Beam Therapeutics
Price & Volume
Stats
See more52W Range | $15.60-$36.44 |
Market Cap | $3.5B |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $164M |
Revenue Growth (YoY) | 324.9% |
Gross Profit (12 Mos) | -$240.9M |
Diluted EPS | -$0.49 |
News
See moreYahoo Finance • 19 days ago
Draft FDA guidance could be a boon for gene therapy developers
Yahoo Finance • 27 days ago
Better Gene-Editing Stock: CRISPR Therapeutics or Beam Therapeutics?
Yahoo Finance • last month
Hedge Fund Drops $40 Million on Gene-Editing Biotech Beam. Is It a Buy?
About
CEO | Mr. John M. Evans M.B.A. |
Address | 238 Main Street, Cambridge, MA, United States, 02142 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 522 |